Pediatric Pulmonary Hypertension Research Fund
It is believed that in the United States, pulmonary arterial hypertension (PAH) will affect 40 – 50 pediatric patients per million children at some point in their lives. While
research has come incredibly far in the last 15 years or so, with thirteen approved PH therapies, none of these therapies is approved for use in children. That's why the Pulmonary Hypertension Association is committed to funding groundbreaking pediatric research. Please support our event and provide hope for Jackson and other children fighting this disease!